‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

(2013) Olga Golubnitschaja et al.   EPMA Journal

The benefits and harms of breast cancer screening: an independent review

(2012)   LANCET

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality

(2011) Montserrat Vera-Llonch et al.   BMC CANCER

Noninvasive subcellular imaging in breast cancer risk assessment: construction of diagnostic windows

(2011) Kristina Yeghiazaryan et al.   Personalized Medicine

Role of circulating tumor cells and disseminated tumor cells in primary breast cancer

(2011) Naoki Hayashi et al.   Breast Cancer

Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening

(2010) R. A. Smith et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breast Cancer Metastasis: Challenges and Opportunities

(2009) J. Lu et al.   CANCER RESEARCH

How effective are breast cancer screening programmes by mammography? Review of the current evidence

(2009) Doris Schopper et al.   EUROPEAN JOURNAL OF CANCER

Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated With 21st-Century Cancer Drug Pricing

(2009) Bruce E. Hillner et al.   JOURNAL OF CLINICAL ONCOLOGY

Guideline implementation for breast healthcare in low-income and middle-income countries

(2008) Benjamin O. Anderson et al.   CANCER